ATE325618T1 - Verwendung des nervenwachstumfaktors zur herstellung eines arzneimittels zur behandlung von erkrankungen der innenaugegeweb - Google Patents
Verwendung des nervenwachstumfaktors zur herstellung eines arzneimittels zur behandlung von erkrankungen der innenaugegewebInfo
- Publication number
- ATE325618T1 ATE325618T1 AT00901331T AT00901331T ATE325618T1 AT E325618 T1 ATE325618 T1 AT E325618T1 AT 00901331 T AT00901331 T AT 00901331T AT 00901331 T AT00901331 T AT 00901331T AT E325618 T1 ATE325618 T1 AT E325618T1
- Authority
- AT
- Austria
- Prior art keywords
- growth factor
- nerve growth
- diseases
- treatment
- production
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/48—Nerve growth factor [NGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Ophthalmology & Optometry (AREA)
- Psychology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT1999RM000069A IT1305294B1 (it) | 1999-01-29 | 1999-01-29 | Uso del nerve growth factor nella terapia di patologie a carico deitessuti intraoculari. |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE325618T1 true ATE325618T1 (de) | 2006-06-15 |
Family
ID=11406408
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT00901331T ATE325618T1 (de) | 1999-01-29 | 2000-01-21 | Verwendung des nervenwachstumfaktors zur herstellung eines arzneimittels zur behandlung von erkrankungen der innenaugegeweb |
Country Status (11)
Country | Link |
---|---|
US (3) | US9468665B1 (de) |
EP (1) | EP1161256B1 (de) |
AT (1) | ATE325618T1 (de) |
AU (1) | AU2129200A (de) |
CY (1) | CY1106140T1 (de) |
DE (1) | DE60027878T2 (de) |
DK (1) | DK1161256T3 (de) |
ES (1) | ES2264416T3 (de) |
IT (1) | IT1305294B1 (de) |
PT (1) | PT1161256E (de) |
WO (1) | WO2000044396A1 (de) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1305294B1 (it) | 1999-01-29 | 2001-05-04 | Alessandro Lambiase | Uso del nerve growth factor nella terapia di patologie a carico deitessuti intraoculari. |
AU2003287930A1 (en) | 2002-12-20 | 2004-07-14 | Neuronicon Aps | Modulation of activity of neurotrophins |
ITRM20050447A1 (it) * | 2005-08-19 | 2007-02-20 | Anabasis S R L | Uso del nerve growth factor in collirio nella terapia di patologie del sistema nervoso centrale, quali la malattia di alzheimer e il morbo di parkinson. |
ES2624180T3 (es) | 2006-12-21 | 2017-07-13 | H. Lundbeck A/S | Modulación de la actividad de proneurotrofinas |
IT1396607B1 (it) | 2009-11-16 | 2012-12-14 | Hmfra Hungary Ltd Liability Company | Preparazioni oftalmiche a base di bdnf (brain-derived neurotrophic factor) e loro uso. |
IT202000032423A1 (it) | 2020-12-24 | 2022-06-24 | Univ Degli Studi Di Trieste | Metodo per la produzione di forme processate proteoliticamente di fattori trofici o fattori di crescita |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE382477C (de) | 1923-10-03 | Willy Pietzsch | Vorrichtung zum Versenken von Schreibmaschinen in Schreibmaschinentischen, bei der die Schreibmaschine in wagerechter Lage nach einem seitlich in anderer Hoehenlage befindlichen Standplatz auf und ab bewegt wird | |
US4959319A (en) | 1985-08-01 | 1990-09-25 | Skelnik Debra L | Process of corneal enhancement |
NZ226171A (en) | 1987-09-18 | 1990-06-26 | Ethicon Inc | Gel formulation containing polypeptide growth factor |
US4973466A (en) * | 1988-06-21 | 1990-11-27 | Chiron Ophthalmics, Inc. | Wound-healing dressings and methods |
DE3827477A1 (de) | 1988-08-12 | 1990-02-22 | Biotechnolog Forschung Gmbh | Verfahren zur isolierung und zur alleinigen zuechtung von endothelialzellen der menschlichen hornhaut (hcec) |
US5260059A (en) * | 1989-04-14 | 1993-11-09 | The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon Health Sciences University | Treatment of open-angle glaucoma by modulation matrix metalloproteinases and their inhibitor |
US5667968A (en) * | 1989-08-30 | 1997-09-16 | Regeneron Pharmaceuticals, Inc. | Prevention of retinal injury and degeneration by specific factors |
US5641479A (en) | 1991-02-12 | 1997-06-24 | Richardson-Vicks Inc. | Cosmetic compositions comprising an imidazolium derivative and branched polyethylene glycol |
US5272135A (en) | 1991-03-01 | 1993-12-21 | Chiron Ophthalmics, Inc. | Method for the stabilization of methionine-containing polypeptides |
IT1255657B (it) | 1992-05-29 | 1995-11-09 | Colture di tessuto di mucosa congiuntivale differenziata, procedimentoper la loro preparazione e supporti per il loro uso. | |
US5767079A (en) * | 1992-07-08 | 1998-06-16 | Celtrix Pharmaceuticals, Inc. | Method of treating ophthalmic disorders using TGF -β |
US6063757A (en) * | 1995-11-29 | 2000-05-16 | Urso; Richard G. | Wound treatment method with nerve growth factor |
US5641749A (en) * | 1995-11-29 | 1997-06-24 | Amgen Inc. | Method for treating retinal ganglion cell injury using glial cell line-derived neurothrophic factor (GDNF) protein product |
US5641750A (en) * | 1995-11-29 | 1997-06-24 | Amgen Inc. | Methods for treating photoreceptors using glial cell line-derived neurotrophic factor (GDNF) protein product |
IT1283911B1 (it) | 1996-02-05 | 1998-05-07 | Farmigea Spa | Soluzioni oftalmiche viscosizzate con polisaccaridi della gomma di tamarindo |
US6299895B1 (en) * | 1997-03-24 | 2001-10-09 | Neurotech S.A. | Device and method for treating ophthalmic diseases |
CN1233963A (zh) | 1996-09-13 | 1999-11-03 | 有限会社最先端医学研究所 | 神经营养因子的眼科用组合物、视神经机能障碍治疗药和视神经机能障碍治疗方法 |
JPH10218787A (ja) * | 1997-02-06 | 1998-08-18 | Akio Okamoto | 神経栄養因子による眼科用組成物 |
IT1291892B1 (it) * | 1997-04-24 | 1999-01-21 | Alessandro Lambiase | Uso del nerve growth factor nella conservazione di cornee in coltura, nella produzione di tessuti corneali e congiuntivali in vitro e nella |
AU8559398A (en) | 1998-08-05 | 2000-02-28 | Advanced Medicine Research Institute | Remedies for cerebral central lesions with the use of neurotrophic factors |
EP1135105B1 (de) | 1998-12-09 | 2005-03-02 | Chiron Corporation | Verwendung eines neurologischen wirkstoffes zur herstellung eines medikamentes zur behandlung von erkrankungen des zentralen nervensystems |
IT1305294B1 (it) | 1999-01-29 | 2001-05-04 | Alessandro Lambiase | Uso del nerve growth factor nella terapia di patologie a carico deitessuti intraoculari. |
US20020009498A1 (en) | 1999-11-05 | 2002-01-24 | Guy L. Clifton | Methods and compositions for treatment of traumatic brain injury |
IL147921A0 (en) | 2002-01-31 | 2002-08-14 | Abdulrazik Mohammad | A method for treating central nervous system disorders by ocular dosing |
-
1999
- 1999-01-29 IT IT1999RM000069A patent/IT1305294B1/it active
-
2000
- 2000-01-21 EP EP00901331A patent/EP1161256B1/de not_active Expired - Lifetime
- 2000-01-21 AT AT00901331T patent/ATE325618T1/de active
- 2000-01-21 PT PT00901331T patent/PT1161256E/pt unknown
- 2000-01-21 WO PCT/IT2000/000016 patent/WO2000044396A1/en active Search and Examination
- 2000-01-21 AU AU21292/00A patent/AU2129200A/en not_active Abandoned
- 2000-01-21 ES ES00901331T patent/ES2264416T3/es not_active Expired - Lifetime
- 2000-01-21 US US09/890,088 patent/US9468665B1/en not_active Expired - Fee Related
- 2000-01-21 DK DK00901331T patent/DK1161256T3/da active
- 2000-01-21 DE DE60027878T patent/DE60027878T2/de not_active Expired - Lifetime
-
2006
- 2006-08-08 CY CY20061101109T patent/CY1106140T1/el unknown
-
2012
- 2012-02-14 US US13/372,742 patent/US9345749B2/en not_active Expired - Fee Related
-
2016
- 2016-09-14 US US15/264,987 patent/US10010586B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
PT1161256E (pt) | 2006-09-29 |
AU2129200A (en) | 2000-08-18 |
US20120142591A1 (en) | 2012-06-07 |
WO2000044396A1 (en) | 2000-08-03 |
IT1305294B1 (it) | 2001-05-04 |
US9345749B2 (en) | 2016-05-24 |
EP1161256B1 (de) | 2006-05-10 |
EP1161256A1 (de) | 2001-12-12 |
DE60027878T2 (de) | 2007-04-19 |
ES2264416T3 (es) | 2007-01-01 |
US10010586B2 (en) | 2018-07-03 |
ITRM990069A1 (it) | 2000-07-29 |
DE60027878D1 (de) | 2006-06-14 |
CY1106140T1 (el) | 2011-06-08 |
US9468665B1 (en) | 2016-10-18 |
US20170007670A1 (en) | 2017-01-12 |
DK1161256T3 (da) | 2006-09-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Cantor et al. | Glaucoma in the Maroteaux-Lamy syndrome | |
CY1106140T1 (el) | Χρηση νευρικου αυξητικου παραγοντα για την παρασκευη ενος φαρμακου για την θepαπεια παθολογικων καταστασεων του ενδοφθαλμικου ιστου | |
KR102256185B1 (ko) | 멜라닌 및 멜라닌 유사체, 전구체, 및 유도체로 안과 질병, 질환, 및 증상의 치료 및 예방을 위한 방법 | |
AU2021356807A9 (en) | Use of penehyclidine in treatment or prevention of vision-impairing eye diseases | |
CN105854021A (zh) | 具有镇痛、抑菌双重效果的外用药物、制剂及其制备方法 | |
DE60129322D1 (de) | Apoptotische körper zur verwendung in der behandlung von neurodegenerativen und sonstigen nervenerkrankungen | |
O'brien et al. | Doryl in the treatment of glaucoma simplex | |
DE69028877D1 (de) | Verwendung von Phenylethanolaminen zur Herstellung von Medikamenten gegen Augenleiden | |
IT9020968A1 (it) | Composto farmaceutico a base di un antocianidina per il trattamento di malattie oftalmiche | |
DE69614553D1 (de) | Aromatische carbonsaürediamide mit antigastrin wirkung, ihre herstellung und pharmazeutische verwendung | |
RU2322243C1 (ru) | Фармацевтическая композиция для лечения поражений роговицы | |
RU2071303C1 (ru) | Способ лечения помутнений прозрачных сред глаза | |
RU2163123C2 (ru) | Глазные капли | |
RU2104678C1 (ru) | Способ лечения заболеваний глаза | |
RU2090165C1 (ru) | Способ лечения поражений роговицы | |
RU2221584C2 (ru) | Препарат для лечения офтальмологических заболеваний | |
RU2402303C1 (ru) | Способ лечения врастания эпителия | |
Sichel et al. | A case of sympathetic ophthalmitis of unusual onset responding satisfactorily to treatment | |
RU2117466C1 (ru) | Способ профилактики и лечения глазных заболеваний | |
RU2131233C1 (ru) | Способ лечения глаукомы | |
RU2314793C2 (ru) | Способ получения глазных пленок | |
Ascher et al. | sure experiments dealing with the effects of ischemia upon the retinal function. | |
US20060058345A1 (en) | Use of papaverine-like vasodilator and pharmaceutical composition | |
Crisp | Colorado Ophthalmological Society | |
Von der Heydt | Chicago Ophthalmological Society: February 21, 1944 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1161256 Country of ref document: EP |